|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-5-13
|
|
pubmed:abstractText |
To determine if a single intravitreal injection of 4 mg of triamcinolone acetonide in patients with classic choroidal neovascularization associated with age-related macular degeneration can safely reduce the risk of severe visual loss.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-9950
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
667-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12742844-Aged,
pubmed-meshheading:12742844-Choroidal Neovascularization,
pubmed-meshheading:12742844-Double-Blind Method,
pubmed-meshheading:12742844-Female,
pubmed-meshheading:12742844-Fluorescein Angiography,
pubmed-meshheading:12742844-Glucocorticoids,
pubmed-meshheading:12742844-Humans,
pubmed-meshheading:12742844-Injections,
pubmed-meshheading:12742844-Intraocular Pressure,
pubmed-meshheading:12742844-Macular Degeneration,
pubmed-meshheading:12742844-Male,
pubmed-meshheading:12742844-Prospective Studies,
pubmed-meshheading:12742844-Safety,
pubmed-meshheading:12742844-Triamcinolone Acetonide,
pubmed-meshheading:12742844-Vision Disorders,
pubmed-meshheading:12742844-Visual Acuity,
pubmed-meshheading:12742844-Vitreous Body
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.
|
|
pubmed:affiliation |
Save Sight and Eye Health Institute, and the Department of Clinical Ophthalmology, University of Sydney, New South Wales, Australia. mark@eye.usyd.edu.au
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
